The global Chromoendoscopy Agents market gathered revenue around USD 102 Million in 2020 and market is set to grow USD 198 Million by the end of 2027 and is estimated to expand at a modest CAGR of 3.1% during the prediction period 2021 to 2027. Chromoendoscopy, particularly in combination with magnifying endoscopy, has helped healthcare professionals in the detection of neoplastic lesions in the gastrointestinal mucosa, specifically in ulcerative colitis and Crohn’s colitis. Chromoendoscopy is helpful in the upper gastrointestinal tract, primarily in evaluating Barrett’s oesophagus (BO) for the presence of dysplasia. It also improves visualization and detection of suspicious lesions, and helps to define the extent of neoplastic lesions that may be responsive to endoscopic resection. Such advantages associated with chromoendoscopy over conventional white light endoscopy are expected to contribute to market growth.
The global population is aging rapidly. According to the WHO, nearly 2 billion people are expected to be aged 60 and above by 2050, which is around 16.9% of the global population. Incidence and prevalence of gastrointestinal diseases (GI), such as colorectal and pancreatic cancers, inflammatory bowels disease, and gastroesophageal reflux disease (GERD), increase with age. Several of these conditions can be diagnosed or cured by using endoscopy procedures. Hence, increase in geriatric population and surge in incidence of diseases are expected to boost the demand for chromoendoscopy agents.
Moreover, favorable medical reimbursement policies for different endoscopy procedures in developed countries such as the U.S., Australia, New Zealand, the U.K., and Germany have enabled most people affected with gastrointestinal diseases to opt for effective endoscopic procedure. These reimbursement policies have driven the revenue of leading players in the international market.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Chromoendoscopy Agents market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Chromoendoscopy Agents market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Chromoendoscopy Agents market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America to Dominate Global Market; Asia Pacific to Offer Significant Opportunities
In terms of region, the global chromoendoscopy agents market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to account for a prominent share of the global chromoendoscopy agents market during the forecast period. High awareness about latest healthcare technologies and purchasing power is anticipated to boost the chromoendoscopy agents market in North America. Favorable reimbursement policies in the region also enable patients to avail the best healthcare facilities.
The chromoendoscopy agents market in Europe is expected to expand at a high CAGR in the near future. Developed healthcare infrastructure in the region has helped patients undergoing chromoendoscopy in covering their expenditure. Most healthcare providers in countries such as Germany, the U.K., and France provide full or partial coverage of costs related to treatment, medication, physician cost, and tests depending on the patient’s insurance plan and income.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Chromoendoscopy Agents Market are:
The global chromoendoscopy agents market are Cosmo Pharmaceuticals NV., Merck KGaA, Thermo Fisher Scientific, Provepharm Life Solutions, Enzo Life Sciences, Inc., American Regent, Inc., Micro-Tech Endoscopy, Cerba Research, Sisco Research Laboratories Pvt. Ltd., and LobaChemie Pvt. Ltd., among others.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global Chromoendoscopy Agents Market: Segmentation
Chromoendoscopy Agents Market, by Product Type
- Absorptive Agents
- Contrast Agents
- Reactive Agents
Chromoendoscopy Agents Market, by Application
- Esophageal
- Gastric
- Colorectal
Chromoendoscopy Agents Market, by End User
- Hospitals
- Ambulatory Surgery Centers
- Specialty Clinics
- Diagnostic Centers
- Others
By Geography
North America
Europe
- Germany
- France
- United Kingdom
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
The study objectives of this report are:
- To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2027);
- Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
Download Sample
Request Customization
Request Customization
Download Sample
